BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12384555)

  • 1. Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.
    Esteller M; Guo M; Moreno V; Peinado MA; Capella G; Galm O; Baylin SB; Herman JG
    Cancer Res; 2002 Oct; 62(20):5902-5. PubMed ID: 12384555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; To KF; Choy KW; Chan FL; Mok SC; Huang DP
    Neoplasia; 2005 Jan; 7(1):67-74. PubMed ID: 15720818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer.
    Jerónimo C; Henrique R; Oliveira J; Lobo F; Pais I; Teixeira MR; Lopes C
    J Clin Pathol; 2004 Aug; 57(8):872-6. PubMed ID: 15280411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk.
    Bistulfi G; Pozzi S; Ren M; Rossetti S; Sacchi N
    Cancer Res; 2006 Nov; 66(21):10308-14. PubMed ID: 17079450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
    Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
    Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
    Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
    Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
    Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
    Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
    Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
    Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.